幹細胞論壇

國際幹細胞學會日前宣佈[年度幹細胞研究之青年傑出獎]為義大利的科學家Dr. Cinzia Rota,其發表的論文為"臍帶血中的間葉幹細胞對急性腎臟疾病的治療淺力" 已發表於幹細胞期刊 (Journal of Stem Cell)中.

Dr.Rota表示幹細胞的研究在未來的十年要從臨床試驗進入到臨床治療,將來會是治療的主要趨勢,他並鼓勵年輕學者多朝幹細胞的再生醫學領域作研究,造福更多的人.

STEM CELLS Journal Awards Human Cord-Blood Research

Durham, NC & Seoul, Korea (Vocus) November 11, 2010

The journal STEM CELLS has announced Dr. Cinzia Rota as the winner of the annual STEM CELLS Young Investigator Award. Co-sponsored by the International Stem Cell Symposium, the $10,000 prize is annually given to a young scientist who is the principal author of a research paper published in STEM CELLS and judged to be most important by the Journal editors.

Dr. Rota, from the Mario Negri Institute for Pharmacological Research in Bergamo, Italy, was awarded the prize for her paper entitled 'Life-Sparing Effect of Human Cord Blood-Mesenchymal Stem Cells in Experimental Acute Kidney Injury.'

"The translation of pre-clinical results into therapies will be an important aspect of stem cell research over the next ten years" said Rota. "Students entering this field should know that it is fascinating, with the opportunity to produce results that can potentially be translated in clinical practice, providing hope in areas where traditional medicine does not offer therapeutic opportunities."

Dr. Rota's award winning paper investigated the potential of human cord blood to cure acute kidney injury. The research revealed the potential for of human cord-blood stem cells as a future cell therapy.

"I think that one of the most important things for the public to understand is the different characteristics and regenerative potentials of human embryonic and adult stem cells; that these cells are not interchangeable, and that one or the other may be better for certain clinical applications," said Rota. "Therefore, detailed studies on ESCs, iPS cells, and adult stem cell are all necessary to provide for future cell therapy applications."

The award was announced at the annual International Stem Cell Symposium, hosted at the Catholic University of Korea in Seoul.

"Stem cell science is one of the most attractive fields for those who are interested in fundamental basic science as well as its clinical application. Ambitious young scientists are absolutely welcome in this exciting field," said Professor Il-Hoan Oh, Director of The Catholic University of Korea's Cell & Gene Therapy Institute and chair of the Symposium's organizing committee. "We need to remember that ultimately we are working to advance stem cell science to help people and our society."

Read more: http://www.sfgate.com/cgi-bin/article.cgi?f=/g/a/2010/11/11/prweb4775444.DTL#ixzz15JpOjGrx